Allaying fears of stockists and retailers about differential tax burden on account of transition to Goods and Services Tax (GST) regime and ensuring uninterrupted supply of medicines to consumers, several pharmaceutical companies have promised their stockists and retailers to compensate any losses on sale of their existing inventory after GST kicks in. Many companies have already written to their stockists, distributors and retailers assuring compensation for financial losses during the transition.

Allaying fears of stockists and retailers about differential tax burden on account of transition to Goods and Services Tax (GST) regime and ensuring uninterrupted supply of medicines to consumers, several pharmaceutical companies have promised their stockists and retailers to compensate any losses on sale of their existing inventory after GST kicks in. Many companies have already written to their stockists, distributors and retailers assuring compensation for financial losses during the transition.